
- Telehealth Visits

Sofia Verstraete, MD
Pediatric GastroenterologyCo-director, Pediatric Inflammatory Bowel Disease Program, San Francisco- Telehealth Visits



Sofia Verstraete, MD
Pediatric GastroenterologyCo-director, Pediatric Inflammatory Bowel Disease Program, San Francisco- Telehealth Visits
On this page
About me
Dr. Sofia Verstraete is a gastroenterologist specializing in inflammatory bowel disease (IBD) – both ulcerative colitis and Crohn's disease – in children. She performs diagnostic and therapeutic procedures, including colonoscopies and other endoscopies, and cares for hospitalized patients as well as those visiting the clinic. Her special interests include IBD that develops at an early age, the ways in which rare conditions of chronic immunodeficiency relate to IBD, liver disease in patients with IBD and how to safely transition IBD patients to other providers' care.
Verstraete is a strong advocate for diversity. As a native Spanish speaker, she can evaluate treat patients who speak only Spanish, bringing particular value to medically complex cases where language and cultural barriers pose challenges. She is co-director of the UCSF Benioff Children's Hospital's Pediatric Inflammatory Bowel Disease Program and leads its clinical, research and quality improvement teams. She is passionate about improving remission rates among IBD patients at UCSF by offering a support group, hosting educational events, connecting patients with resources and creating subspecialty clinics to address the needs of patients who have other conditions along with IBD.
One focus of Verstraete's current research is how medical professionals classify IBD in pediatric patients. Her research also investigates how ethnicity impacts the condition's characteristics. In addition, she is active in clinical trials of cutting-edge medications for pediatric IBD.
After earning her medical degree from the Universidad Nacional Autónoma de México, Verstraete completed a residency in pediatrics at the University of Miami Health System. She then completed a master of advanced studies degree in epidemiology and biostatistics as well as a fellowship in pediatric gastroenterology, hepatology and nutrition at UCSF.
Verstraete belongs to the American Academy of Pediatrics; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition; American Association for the Study of Liver Diseases; Crohn's & Colitis Foundation; and American Gastroenterological Association. She is a John A. Watson Faculty Scholar at UCSF, an honor that has allowed her to dedicate time to research and caring for underserved populations. She also manages the educational programs that give UCSF medical students and residents an opportunity to expand their knowledge of pediatric gastroenterology.
Education
Board Certification
- Pediatric Gastroenterology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Residency
- Jackson Memorial Hospital
Internship
- Jackson Memorial Hospital
School
- MD, Universidad Nacional Autonoma de Mexico
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Pediatric Gastroenterology
Conditions
- Irritable Bowel Syndrome
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Clinical trials
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)Opens in a new window
Recruiting
Clinical Remission based on the MMSClinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's DiseaseOpens in a new window
Recruiting
The achievement of complete healing (CH) 52 weeks after initiation of anti-TNF therapy guided by ROADMAB™ (therapeutic drug monitoring) as evidenced by a compo...
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
